After Hours
$
82.45
Change
-0.01 -0.01%
Volume
Volume 438,964
Jan 20, 2021, 7:58 p.m.
Quotes are delayed by 20 min
Previous close
$ 83.19
$ 82.46
Change
-0.73 -0.88%
Day low
Day high
$82.27
$83.55

52 week low
52 week high
$65.25
$90.46

Market cap
$210.47B
Average volume
8.93M
P/E ratio
18.21
Rev. per Employee
$656,141
EPS
4.53
Dividend
0.65
Div yield
3.15%
Ex dividend date
12/14/20
MarketWatch News on MRK
-
Eli Lilly Stock Is Still Pricey. Why It Might Be a Buy.
- Josh Nathan-Kazis
-
Dow flat in spite of losses in shares of IBM, Dow Inc.
- MarketWatch Automation
-
Dow flat despite losses for shares of Merck, Walt Disney
- MarketWatch Automation
-
Merck, Visa share losses contribute to Dow's nearly 100-point fall
- MarketWatch Automation
-
Illumina CEO Says Business Is Bouncing Back
- Bill Alpert
-
A Start-Up That Wants to Undersell the Drug Industry Raises Another $500 Million
- Josh Nathan-Kazis
-
3M, Goldman Sachs share losses lead Dow's 69-point drop
- MarketWatch Automation
-
Dow's nearly 175-point drop led by losses for shares of 3M, Verizon Communications Inc.
- MarketWatch Automation
-
3M, Goldman Sachs share losses lead Dow's 89-point drop
- MarketWatch Automation
-
Travelers, Walmart share losses lead Dow's nearly 50-point drop
- MarketWatch Automation
-
Merck Stock Is Deeply Undervalued, Says Citi. It Could Surge in 2021.
- Josh Nathan-Kazis
-
Our Top 10 Stocks for the New Year
- Andrew Bary
-
Best Income Investments for 2021
- Andrew Bary
-
These are the best-performing Nasdaq and S&P 500 stocks of 2020
- Philip van Doorn
-
How the Dow Industrials Trailed the S&P 500 in 2020
- Andrew Bary
- Loading more headlines...
Analyst Ratings
-
Analysts Cut Target Prices on MYL Stock after Its Q2 2018 Results
- MarketRealist.com
-
Amgen Stock in May: A Substantial Rise
- MarketRealist.com
-
Analysts’ Recommendations for Merck, Post-1Q18 Results
- MarketRealist.com
Other News on MRK
-
Merck KGaA, GSK end Phase 3 trial for cancer drug; shares fall
- Seeking Alpha
-
The 7 Best Healthcare Stocks to Buy for 2021
- InvestorPlace.com
-
10 Dividend Growth Stocks For January 2021
- Seeking Alpha
-
Merck/Bayer's Verquvo OK'd in U.S. for chronic heart failure
- Seeking Alpha
-
Gilead up nearly 6% on Morgan Stanley upgrade to overweight
- Seeking Alpha
-
Invest Like A Billionaire With High Yield: THW
- Seeking Alpha
-
Dividend Growth Pharmaceuticals For 2021
- Seeking Alpha
-
Monthly Review Of DivGro: December 2020
- Seeking Alpha
-
Among The Dogs Of The DOW, Merck Is The Best Of Breed
- Seeking Alpha
- Loading more headlines...
Press Releases on MRK
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com